Showing results (141-150 of 306) with videos related to

Sort By:
Pageof 31
The American Journal of Physiology|February 1, 1990
Interaction between left ventricular end-diastolic and end-systolic volumes in normal humansD G Renlund, G Gerstenblith, J L Fleg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1988
Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogsQ S Li, T L Frank, D Franceschi, et al.
Circulation|August 1, 1979
Measurement of aortic and mitral regurgitation by gated cardiac blood pool scansP Rigo, P O Alderson, R M Robertson, et al.
Journal of the American College of Cardiology|February 11, 1991
Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarctionK Takeda, N D LaFrance, H F Weisman, et al.
Journal of Molecular and Cellular Cardiology|March 12, 1999
Age-related decrease in cardiac tolerance to oxidative stressP Abete, C Napoli, G Santoro, et al.
Acta Neurologica|December 1, 1993
Hindbrain hernia headache and syncope in type I Arnold-Chiari malformationV Palma, L Sinisi, V Andreone, et al.
Journal of Cardiovascular Pharmacology|May 1, 1985
Mepindolol reduces myocardial necrosis in rats with coronary artery occlusionM Chiariello, G Ambrosio, M Cappelli-Bigazzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1990
Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI)Q S Li, G Solot, T L Frank, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusionM Chiariello, G Ambrosio, M Cappelli-Bigazzi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumorsN Panza, P F Rambaldi, C Battista, et al.
Pageof 31